The Three Main Blood Cancers

---

Blood cancer is an umbrella term for cancers that affect the blood cells or the bone marrow where they are made. There are three main types, and they behave quite differently — which is why the right diagnosis from an experienced haematologist matters so much.

Leukaemia is a cancer of the blood and bone marrow, in which the body overproduces abnormal white blood cells. It can be acute (fast-growing, needing urgent treatment) or chronic (slower). Lymphoma begins in the lymphatic system — the lymph nodes and lymph tissue — and is divided into Hodgkin and non-Hodgkin types. Multiple myeloma is a cancer of the plasma cells in the bone marrow, which crowds out healthy cells.

Each is treated differently, and within each there are subtypes that change the plan entirely. This is why a precise diagnosis — confirmed by an accredited laboratory — is the foundation of good blood cancer care.

How Blood Cancers Are Treated

---

Unlike solid tumours, blood cancers are rarely treated with surgery. The mainstays are drug-based and cellular therapies, chosen by a haemato-oncology team based on the exact diagnosis.

Chemotherapy remains central, often given in phases over months. Targeted therapy attacks specific features of the cancer cells, and immunotherapy harnesses the immune system. Radiation is used in some lymphomas. And for many aggressive or relapsed blood cancers, a bone marrow transplant offers the best chance of cure.

For relapsed or refractory disease that has not responded to standard treatment, CAR-T cell therapy — in which the patient's own immune cells are re-engineered to attack the cancer — is now available at select Indian centres, at far lower cost than in the West and with studies reporting around 80 percent response rates.

Bone Marrow Transplant — What It Involves

---

A bone marrow transplant — also called a stem cell transplant — replaces diseased blood-forming cells with healthy stem cells. It can cure certain blood cancers or significantly prolong remission, and India is a global leader in performing it.

There are two main types. An autologous transplant uses the patient's own stem cells, collected and returned after high-dose chemotherapy. An allogeneic transplant uses cells from a matched donor — a sibling, an unrelated match, or in haploidentical transplants a half-matched family member. The choice depends on the disease, the patient and the availability of a donor.

The procedure itself is not a surgery — the stem cells are given through a drip. The intensive part is the weeks afterwards, when the new marrow rebuilds and the patient is vulnerable to infection. This is why a good transplant unit has HEPA-filtered isolation rooms, dedicated transplant ICUs and stringent infection control — features India's leading centres are specifically equipped with.

Success Rates — What to Expect

---

Bone marrow transplant success rates range from roughly 60 to 90 percent, depending on the type of transplant, the quality of the donor match, the specific disease, and the patient's overall health. India's leading transplant centres report outcomes comparable to global standards, following the same international protocols.

That is a wide range, and it should be. Anyone who quotes you a single success figure without knowing your exact diagnosis, your transplant type and your donor situation is not giving you a meaningful number. A responsible haematologist talks about your specific outlook, not a headline statistic.

What you can reasonably expect from a high-volume Indian transplant unit is care that follows the same protocols, uses the same supportive technology, and is delivered by teams who have managed large numbers of complex cases.

Cost of Blood Cancer Treatment in India

---

Blood cancer treatment in India typically costs between USD 5,000 and 30,000, depending on the type of cancer, the treatment needed, and whether a transplant is required. The transplant itself is usually the largest single cost, and it is where the saving against the West is most striking.

Treatment	India	USA (private)
Chemotherapy (per cycle)	USD 400–1,500	USD 3,000–7,000
Autologous bone marrow transplant	USD 18,000–25,000	USD 100,000–200,000
Allogeneic bone marrow transplant	USD 25,000–40,000	USD 200,000–300,000
Targeted / immunotherapy (per dose)	USD 1,000–4,000	USD 5,000–15,000
CAR-T cell therapy	From USD 40,000	USD 400,000+

A transplant means a longer stay than most treatments — typically several weeks in hospital plus recovery time before it is safe to fly. For the full picture across treatments and the total trip cost, see our detailed breakdown of cancer treatment cost in India.

Best Hospitals for Blood Cancer in India

---

For blood cancer, you are choosing a transplant unit as much as a hospital — so the centres with the largest, most experienced bone marrow transplant programmes matter most. The strongest options for international patients combine a high-volume haemato-oncology team with dedicated HEPA-filtered transplant facilities.

In Delhi NCR, BLK-Max, Delhi runs one of the largest bone marrow transplant units in India and is a leading choice specifically for blood cancers, while Fortis FMRI, Gurgaon and Medanta both operate large transplant programmes and treat complex relapsed and refractory cases. The full Delhi line-up is in our best cancer hospitals in Delhi NCR guide.

In Mumbai, Kokilaben has a strong haemato-oncology and paediatric blood cancer programme, set out alongside the city's other centres in our best cancer hospitals in Mumbai guide. In South India, Manipal, Bengaluru offers bone marrow and stem cell transplants for blood cancers, compared with other southern centres in our best cancer hospitals in Bangalore and Chennai guide.

For the full national picture of how these hospitals compare on accreditation, volume and technology, start with our pillar guide to the best cancer hospitals in India, and use our checklist on how to choose a cancer hospital to judge any transplant unit before you commit.